Discontinuation report GD-GABAPENTIN

Last updated on 2019-01-14 History
Report ID 22063
Drug Identification Number 02285827
Brand name GD-GABAPENTIN
Common or Proper name Gabapentin
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 tabs
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-01-06
Remaining supply date 2018-01-06
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-01-14 French Compare
v5 2019-01-14 English Compare
v4 2017-12-08 French Compare
v3 2017-12-08 English Compare
v2 2017-09-21 French Compare
v1 2017-09-13 English Compare

Showing 1 to 6 of 6